The rising landscape of Indian pharmaceuticals is witnessing significant interest on Retatrutide, a new dual GIP and GLP-1 target exhibiting potential for weight management . This protein is generating considerable buzz within the medical community, particularly as domestic companies pursue distribution partnerships . The present situation invol… Read More